ArticleJournal for immunotherapy of cancer2026

Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage response.

Huili Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.